MEDICAL TRANSCRIPTION BILLING, CORP. (NASDAQ:MTBCP) Files An 8-K Results of Operations and Financial ConditionItem 2.02
On July 17, 2017, the Registrant issued a letter to shareholders, a copy of which is attached hereto as Exhibit 99.1 and is incorporated herein by reference.
The information furnished to Item 2.02 of this Form 8-K shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any other filing under Securities Act of 1933, as amended or the Exchange Act, except as expressly set forth by specific reference in such a filing.
| Item 9.01 | Financial Statements and Exhibits. |
| Exhibit 99.1 | Letter to Shareholders dated July 17, 2017. |
(S)
MEDICAL TRANSCRIPTION BILLING, CORP ExhibitEX-99.1 2 ex99-1.htm Exhibit 99.1 MTBC First Half 2017 Shareholder Update SOMERSET,…To view the full exhibit click here
